Redesigning obesity trials for a chronic disease era
For much of its history, obesity research has occupied an awkward space within clinical development. Too medical to dismiss outright, yet, too entangled with lifestyle narratives to command the same seriousness as closely linked conditions like cardiovascular disease or diabetes, it has often been studied through a narrow lens – short trials, blunt endpoints, and a lingering assumption that weight loss alone was the outcome that mattered.
Industry Events & Conferences
SaxoCell Conference on Cell and Gene Therapy
Explore the Future of Cell and Gene Therapy Development hVIVO will be attending the SaxoCell Conference, a focused ...
Capital Markets Day 2026
The event will provide investors with a deeper understanding of hVIVO's strategic evolution from specialist human ...
11th German Pharm-Tox Summit 2026
The GPTS is organized by the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT). The ...
PSI 2026
Join us at the PSI 2026 Conference, taking place 15–17 June at the award‑winning ICC Belfast. This year’s event brings ...
PCMG26
PCMG26 is a leading annual gathering for professionals in pharmaceutical clinical outsourcing, vendor management, and ...
BIO International Convention
hVIVO is proud to be attending BIO International Convention 2026, the world’s largest gathering of biotechnology, ...
American Society for Virology
The American Society for Virology (ASV) is a premier scientific organisation dedicated to advancing the understanding ...
Options XIII
Options XIII is a major global conference dedicated to advancing influenza science, policy, and pandemic preparedness, ...
ERS Congress
The ERS International Congress is one of the world’s leading events in respiratory medicine, bringing together ...
Drug Discovery 2026
Drug Discovery 2026 is a leading UK‑based conference bringing together researchers, biotechs, pharma innovators, and ...
World Vaccine Congress Europe
Meet the Team Accelerate Vaccine Development Through Collaboration and Innovation hVIVO will be attending the World ...
IDWeek 2026
IDWeek 2026 is a premier global meeting for professionals in infectious diseases, epidemiology, infection prevention, ...
Hands On Workshops
Workshop: Build Your Target Product Profile With Confidence
Build your Target Product Profile With Confidence For biotech and start‑up teams balancing innovation with speed, a ...
Inside VC Due Diligence: The Risks Investors Find First
Taking place on the 8th November at 15:00-16:30 CET, this interactive workshop is designed for biotech startups and ...
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
Practical Solutions for Complex Drug Development The journey from concept to First‑In‑Human (FIH) trials is filled with ...
On-Demand Education
Getting Biomarkers Right: Strategy, Execution, and Clinical Relevance in Early Drug Development
Biomarkers can play a critical role in early drug development, helping teams understand biological activity, identify ...
Choosing The Right Moment For Pre‑IND: Integrating US And EU Regulatory Pathways Into Your Strategy
The FDA Pre‑IND review is often approached as a regulatory checkpoint. However, for early‑stage biotechs, deciding when ...
Fast-Tracking First-In-Human: A Startup-Focused Guide to IND Readiness and Early Clinical Success
Practical guidance for startups navigating IND readiness and early clinical planning. Taking a drug candidate from ...
Smarter Molecular Strategies for Infectious Disease Trials: Turning Complex Data into Clinical Advantage
As infectious disease programs face increasing pressure to generate high-quality data faster, integrated molecular ...
The future of cardiometabolic trials: From obesity to outcomes that matter
As obesity continues to reshape the cardiometabolic landscape, early-stage developers face growing pressure to generate ...
.jpg)
Accelerate your RSV Programme with our RSV Human Challenge Model
About RSV & why developing RSV antivirals and vaccines are critical Respiratory Syncytial Virus (RSV) is a common, ...
Accelerate Your hMPV Programme with hVIVO's Challenge Model
Advancing your Human Metapneumovirus (hMPV) research? Discover how the world's only contemporary-strain hMPV human ...
Technical Due Diligence in Drug Development: What Startup Founders Need to Know to Succeed
Join industry experts for an interactive discussion on mastering technical due diligence. Due diligence is a critical ...
News & Resources
Multi-Pathogen Screening in Clinical Research
qPCR vs ddPCR vs NGS: Which Molecular Method?
Why Early-Phase Combination Protocols Are Becoming Essential — And How to Execute Them with Precision
Recruiting for Respiratory Trials Requires More Than a Network — It Requires Understanding the Patient
.png)
Looking Ahead to the World Vaccine Congress Europe — Where Respiratory Vaccine Development Is Heading
Beyond Influenza: Measuring Immune Function in Trials
The Biomarker Gold Rush: Are we collecting data just because we can?
.png)
PK/PD: The Operational Engine Behind Early‑Phase Success
From Buffy Coat to Better Clinical Data: Why PBMC Processing Matters
Designing Early‑Phase Trials with Patients in Mind: The Operational Reality